Mariana Resnicoff
-
- Growth Hormone and Insulin-like Growth Factors 21
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 11
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 7
- Oncology top 10%
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 3
- Genetics top 10%
-
- HIV Research and Treatment 3
-
- Cancer Research and Treatments 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Renato BasergaR RubinDomenico CoppolaChristian SellDavid AbrahamHarris L. RotmanMichele RubiniConsuelo D'Ambrosio
- Partner nations
- United StatesArgentinaFrance
In The Last Decade
Mariana Resnicoff
34 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 86
- Endocrinology, Diabetes and Metabolism 1.2k
- Cancer Research 601
- Molecular Biology 1.5k
- Oncology 455
- Genetics 116
Countries citing papers authored by Mariana Resnicoff
This map shows the geographic impact of Mariana Resnicoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariana Resnicoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariana Resnicoff more than expected).
Fields of papers citing papers by Mariana Resnicoff
This network shows the impact of papers produced by Mariana Resnicoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariana Resnicoff. The network helps show where Mariana Resnicoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mariana Resnicoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 5 | |
| 2 | 1998 | 13 | |
| 3 | 1998 | 43 | |
| 4 | Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. | 1998 | 46 |
| 5 | 1997 | 55 | |
| 6 | 1997 | 68 | |
| 7 | 1997 | 6 | |
| 8 | 1997 | 79 | |
| 9 | 1996 | 40 | |
| 10 | 1996 | 43 | |
| 11 | A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. | 1996 | 143 |
| 12 | 1995 | 50 | |
| 13 | 1994 | 43 | |
| 14 | 1993 | 1 | |
| 15 | 1992 | 14 | |
| 16 | 1992 | 22 | |
| 17 | 1991 | 6 | |
| 18 | 1990 | 9 | |
| 19 | 1989 | 3 | |
| 20 | 1988 | 6 |
About Mariana Resnicoff
Mariana Resnicoff is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Virology, having authored 34 papers that have together received 2.3k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (21 papers), Cancer, Hypoxia, and Metabolism (11 papers), Metabolism, Diabetes, and Cancer (7 papers), Cancer Cells and Metastasis (4 papers), HIV Research and Treatment (3 papers), Cancer Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Cancer Research (601 citations) and Molecular Biology (1.5k citations). Mariana Resnicoff has collaborated with scholars based in United States, Argentina and France. Frequent co-authors include Renato Baserga, R Rubin, Domenico Coppola, Christian Sell, David Abraham, Harris L. Rotman, Michele Rubini, Consuelo D'Ambrosio, Jean‐Luc Burgaud and Raphael Rubin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.